TORONTO, Dec. 02, 2020 (GLOBE NEWSWIRE) — Axiom Real-Time Metrics (“Axiom”), premier provider of unified eClinical solutions and services, is a presenting sponsor and exhibitor at Clinical Trials in Rare Diseases taking place December 7-8th, 2020.
The presentation ‘Rare Disease Studies – Data Challenges & Solutions’, scheduled for December 8th at 1:30 PM EST will feature Andrew Schachter, Axiom’s Founder & CEO and Kaitlyn Townsley, Axiom’s Associate Director of Product Innovation. The panelists will discuss key data challenges and technology solutions pertaining to rare disease studies, along with the advantages of centralized data and eClinical Solutions to manage it.
“Rare disease studies involve critical data from a small number of patients across EDC, ePRO, IWRS and lab data, making study management and access to real time status and reports a challenge. Fusion, Axiom’s unified eClinical platform, allows for study management within one platform providing easy to use technology to oversee Study Compliance and Patient Retention which are so important to rare disease trials. We are excited to speak with attendees and share how Fusion can help manage every aspect of their clinical trials in a single unified platform,” shared Kaitlyn Townsley, Associate Director of Product Innovation.
To register for this event, please visit: https://rarediseases.online-event.co/registration/arena-rare-diseases-3